[go: up one dir, main page]

MX2016011140A - Presente en:. - Google Patents

Presente en:.

Info

Publication number
MX2016011140A
MX2016011140A MX2016011140A MX2016011140A MX2016011140A MX 2016011140 A MX2016011140 A MX 2016011140A MX 2016011140 A MX2016011140 A MX 2016011140A MX 2016011140 A MX2016011140 A MX 2016011140A MX 2016011140 A MX2016011140 A MX 2016011140A
Authority
MX
Mexico
Prior art keywords
topiramate
overweight
obesity treatment
useful
presente
Prior art date
Application number
MX2016011140A
Other languages
Spanish (es)
Inventor
FERNÁNDEZ DEL VALLE LAISEQUILLA Cecilia
Gerardo REYES GARCÍA Juan
Issac Rocha González Héctor
Amalia RUELAS ENSALDO Jazmín
GUTIERREZ MENDOZA Ranier
Romero Gutiérrez Adriana
Original Assignee
Productos Medix S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Productos Medix S A De C V filed Critical Productos Medix S A De C V
Priority to MX2016011140A priority Critical patent/MX2016011140A/en
Publication of MX2016011140A publication Critical patent/MX2016011140A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PHARMACEUTICAL COMPOSITION OF AMFEPRAMONE AND TOPIRAMATE USEFUL IN THE OVERWEIGHT AND OBESITY TREATMENT The present disclosure is related to pharmaceutical combinations and compositions comprising therapeutically effective amounts of amfeptamone and topiramate, and its use in the preparation of drugs useful in the overweight and obesity treatment.
MX2016011140A 2016-08-26 2016-08-26 Presente en:. MX2016011140A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2016011140A MX2016011140A (en) 2016-08-26 2016-08-26 Presente en:.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2016011140A MX2016011140A (en) 2016-08-26 2016-08-26 Presente en:.

Publications (1)

Publication Number Publication Date
MX2016011140A true MX2016011140A (en) 2017-04-20

Family

ID=59067409

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016011140A MX2016011140A (en) 2016-08-26 2016-08-26 Presente en:.

Country Status (1)

Country Link
MX (1) MX2016011140A (en)

Similar Documents

Publication Publication Date Title
PH12020550857A1 (en) Polycyclic compounds as allosteric shp2 inhibitors
MX2025009223A (en) Clec9a binding agents and use thereof
TN2017000554A1 (en) Novel combination for use in the treatment of cancer
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
EA201800199A1 (en) APPLICATION OF AKKERMANSIA MUCINIPHILA FOR THE TREATMENT OF METABOLIC DISORDERS, INCREASE ENERGY CONSUMPTION AND WEIGHT REDUCTION, COMPOSITIONS, MEDICINE
BR112017018368A2 (en) rna-containing compositions for the treatment of tumoral diseases
EA201391644A1 (en) PARTIALLY SATURATED TRICYCLIC COMPOUNDS AND METHODS FOR THEIR RECEPTION AND APPLICATION
MX2018000419A (en) Substituted amide derivatives having multimodal activity against pain.
NZ606768A (en) Pharmaceutical compositions and methods of treatment
PH12016500978A1 (en) Piperazine derivatives having multimodal activity against pain
TW201613578A (en) Pharmaceutical combinations
PH12016502352A1 (en) Pharmaceutical composition
MX2017006437A (en) Spiro-isoquinoline-1,4'-piperidine compounds having multimodal activity against pain.
MX2016006604A (en) Piperidine derivatives having multimodal activity against pain.
ZA201805358B (en) 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX379201B (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2015005732A (en) Tricyclic compounds and methods of making and using same.
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
PH12018502280A1 (en) Tetrahydropyran and thiopyran derivatives having multimodal activity against pain
MX2016004094A (en) Pharmaceutical composition comprising capecitabine and cyclophosphamide.
ZA201906153B (en) Pharmaceutical compositions for combination therapy
PH12018500682A1 (en) Oxa-diazaspiro compounds having activity against pain
MX2016011140A (en) Presente en:.
MX2014005152A (en) Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient.
MX354614B (en) Pharmaceutical composition combining diosmin and hesperidin and its use in neuropathic pain.